BPG is committed to discovery and dissemination of knowledge
Citation
Kashiv P, Saxena K, Balwani MR, Pasari A, Kute VB. Alemtuzumab or basiliximab: Rethinking induction choice beyond acute rejection in kidney transplantation. World J Transplant 2026; 16(3): 118000 [DOI: 10.5500/wjt.118000]
Please LOGIN to submit a new comment.